Not Enrolling, but Ongoing

HBV-HIV Coinfection Observational Cohort, Sponsor: National Instituties of Health
Contact: Bryan Boyachuk
(416)340-4239.

A prospective clinical cohort of HIV and Hepatitis C virus co-infected patients (CTN 222, www.cocostudy.ca)

Contact: Warmond Chan
(416)340-4800 ext. 6954

Completed Studies with Results

Prospective Investigation of the Relationship Between Food Insecurity and Health and Behavioural Outcomes in HIV-HCV Co-infection: Clues for Prevention Interventions. A Food Security & HIV-HCV Sub-study of the Canadian Co-Infection Cohort (CTN 222) (Protocol: CTN 264)

A randomized, placebo-controlled trial of citalopram for the prevention of depression and its consequences in HIV-Hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy. CTN 194, PICCO

An Open Label,Phase 3 Study of Telaprevir in Combination With Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Coinfected With Genotype 1 Hepatitis C Virus and Human Immunodeficiency Virus Type 1(HCV/HIV-1) (VX11-950-115)

A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Co-infection (GS-US-337-0115)

A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1) (AI444-378)

A Phase 3b Open-label Study of the Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1/Hepatitis B Co-infected Adults (GS-US-292-1249)